ANTICOAGULANTS Concerns over data in key dabigatran trial

被引:20
作者
Cohen, Deborah
机构
来源
BMJ-BRITISH MEDICAL JOURNAL | 2014年 / 349卷
关键词
NONVALVULAR ATRIAL-FIBRILLATION; STROKE PREVENTION; WARFARIN; XIMELAGATRAN; EVENTS;
D O I
10.1136/bmj.g4747
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页数:3
相关论文
共 9 条
[1]  
Albers GW, 2005, JAMA-J AM MED ASSOC, V293, P690
[2]  
Albers GW, 2003, LANCET, V362, P1691
[3]  
[Anonymous], 2011, THERAPEUTICS LETT, V80
[4]  
Center for Drug Evaluation and Research, 2010, APPL NUMB 22 512
[5]   Establishing Comparable Requirements and Treatment Groups Before Applying Statistical Comparison Reply [J].
Chatterjee, Saurav ;
Sardar, Partha ;
Biondi-Zoccai, Giuseppe ;
Kumbhani, Dharam J. .
JAMA NEUROLOGY, 2014, 71 (03) :371-372
[6]   ANTICOAGULANTS Dabigatran: how the drug company withheld important analyses [J].
Cohen, Deborah .
BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
[7]   Newly Identified Events in the RE-LY Trial [J].
Connolly, Stuart J. ;
Ezekowitz, Michael D. ;
Yusuf, Salim ;
Reilly, Paul A. ;
Wallentin, Lars .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (19) :1875-1876
[8]   Dabigatran versus Warfarin in Patients with Atrial Fibrillation. [J].
Connolly, Stuart J. ;
Ezekowitz, Michael D. ;
Yusuf, Salim ;
Eikelboom, John ;
Oldgren, Jonas ;
Parekh, Amit ;
Pogue, Janice ;
Reilly, Paul A. ;
Themeles, Ellison ;
Varrone, Jeanne ;
Wang, Susan ;
Alings, Marco ;
Xavier, Denis ;
Zhu, Jun ;
Diaz, Rafael ;
Lewis, Basil S. ;
Darius, Harald ;
Diener, Hans-Christoph ;
Joyner, Campbell D. ;
Wallentin, Lars .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1139-1151
[9]   Myocardial Ischemic Events in Patients With Atrial Fibrillation Treated With Dabigatran or Warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial [J].
Hohnloser, Stefan H. ;
Oldgren, Jonas ;
Yang, Sean ;
Wallentin, Lars ;
Ezekowitz, Michael ;
Reilly, Paul ;
Eikelboom, John ;
Brueckmann, Martina ;
Yusuf, Salim ;
Connolly, Stuart J. .
CIRCULATION, 2012, 125 (05) :669-676